RE: Paradigm reiterated BUY and 80 cent target
Here's what Paradigm says....
HUGE Market Potential for Prometic , Competition is lagging.
First two users are likely to be the Irish Blood Cross and the National Blood Service of the UK... with other Eurpean countries to follow.
Current European Blood collection is 11 million units annually
Bags will sell for US $20-$25 each.
Prometic is expected to keep 60-75% of revenues... with net profit of US $5 -$7 / bag. The new agreement with PRDT / ARC is expected to positive affect Prometics share of these revenues.
Paradigm is predicting that PLI can generate US $100mm from the filters within 3-4 years of launch with a 40 cent / share EPS contribution.